HOME > TOP STORIES

TOP STORIES

BUSINESS Tapped as Next Mitsubishi Tanabe Chief, Hiroaki Ueno Vows to Enrich Pipeline, Accelerate Global Biz

January 15, 2020
BUSINESS Astellas, Adaptimmune Hook Up on Off-the-Shelf Cell Therapies

January 15, 2020
REGULATORY Japan Likely to Take Pass on Rewarding Formulary Initiatives under Medical Fee Schedule

January 14, 2020
BUSINESS Meiji Gains Japan Rights for Novel Blood Cancer Treatment from HUYA Bioscience

January 10, 2020
BUSINESS Keytruda Top New Sales Generator in 2020, Enhertu Seen as Biggest Arrival: Evaluate

January 9, 2020
BUSINESS Daiichi Sankyo’s Blockbuster Hopeful Enhertu Hits US Market

January 8, 2020
ORGANIZATION As Off-Year Re-Pricing Looms, JPMA Chief Prods Govt to Minimize Product Coverage

January 7, 2020
REGULATORY MHLW to Set Up New Study Group on Detailing Activities Report System for All Medical Institutions

January 6, 2020
REGULATORY JETRO’s New York Office Gets First Health and Welfare Head in 2 Years

January 1, 2020
TRENDS 51 Drugs Listed in 2019 with Total Peak Sales Forecast of 370 Billion Yen, Many for Orphan Diseases

December 27, 2019
REGULATORY Councilor Mori Urges Drug Maker Management to Straighten Up as He Bids Farewell to MHLW

December 27, 2019
TRENDS Top 10 PHARMA JAPAN Articles in 2019

December 26, 2019
REGULATORY Japan's Global Health Confab to Prepare New Grand Design for Regulatory Harmonization in Asia

December 26, 2019
BUSINESS Opdivo/Yervoy Combo Filed for Frontline NSCLC in Japan

December 26, 2019
BUSINESS Kyowa Hakko Bio Hit with 18-Day Biz Suspension over GMP Failings

December 25, 2019
BUSINESS 15% Share Eyed for Jointly Developed Symbicort Generics, Toa Set to Push Uptake with Support App

December 25, 2019
BUSINESS Towa to Acquire Spanish Generic Player, Set to Venture into US/European Markets

December 24, 2019
BUSINESS Daiichi Sankyo, AZ Nab US Nod for ADC Enhertu in Breast Cancer

December 24, 2019
REGULATORY Fumi Yamamoto 1st Woman to Become MHLW’s Top Pharmacy Officer

December 23, 2019
REGULATORY Japan Approves Keytruda’s 1st Line RCC, Head and Neck Cancer Use, Bavencio’s Label Expansion and More

December 23, 2019

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests

By Takashi Ebisawa

The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…

COMMENTARY

FY2026 Reform Debate for Drug Pricing Nears the Finish Line, Balance Needed

By Takashi Ebisawa

Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…

COLUMN

AI in HR: Navigating the Ethical Minefield

By Philip Carrigan

Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…